SCHEMBL21384008

SCHEMBL21384008

O=C(O)CSCC(=O)NCCN1CC(O)CC1=O

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ APEX1 P27695 1/20 0.42
▸ BLM P54132 1/20 0.42
▸ FABP4 P15090 2/20 0.37
▸ FABP3 P05413 1/20 0.37
▸ GAA P10253 1/20 0.35
▸ L3MBTL1 Q9Y468 2/20 0.34
▸ MEN1 O00255 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ USP2 O75604 1/20 0.33
▸ MITF O75030 1/20 0.32
▸ KLF5 Q13887 1/20 0.32
▸ TP53 P04637 1/20 0.32
▸ POLB P06746 1/20 0.32
▸ CYP2D6 P10635 1/20 0.32
▸ HIF1A Q16665 1/20 0.32
▸ LMNA P02545 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24796375 1.00 APEX1 (0.42) APEX1BLMFABP4FABP3GAA
SCHEMBL24796275 1.00 APEX1 (0.42) APEX1BLMFABP4FABP3GAA
SCHEMBL26746550 0.88 APEX1 (0.41) APEX1BLMMEN1CYP2C19KMT2A
SCHEMBL26746545 0.88 APEX1 (0.41) APEX1BLMMEN1CYP2C19KMT2A
SCHEMBL30131272 0.87 FABP3 (0.38) APEX1BLMFABP4FABP3GAA
SCHEMBL21384374 0.87 FABP3 (0.38) APEX1BLMFABP4FABP3GAA
SCHEMBL21389487 0.87 FABP3 (0.38) APEX1BLMFABP4FABP3GAA
SCHEMBL21384376 0.87 FABP3 (0.38) APEX1BLMFABP4FABP3GAA
SCHEMBL21383860 0.86 USP2 (0.37) FABP4FABP3GAAL3MBTL1MEN1
SCHEMBL21389303 0.86 USP2 (0.37) FABP4FABP3GAAL3MBTL1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230357347-A1 MODULATORS OF G-PROTEIN COUPLED RECEPTORS CARMOT THERAPEUTICS, INC. 2023-11-09 — — US disclosed
EP-3768294-A1 MODULATORS OF G-PROTEIN COUPLED RECEPTORS Carmot Therapeutics, Inc. (US) 2021-01-27 — — EP disclosed
CN-112236161-A Modulators of G protein-coupled receptors 卡莫特治疗学股份有限公司 2021-01-15 — — CN disclosed
WO-2019183577-A1 MODULATORS OF G-PROTEIN COUPLED RECEPTORS CARMOT THERAPEUTICS, INC. (US) 2019-09-26 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230357347-A1 MODULATORS OF G-PROTEIN COUPLED RECEPTORS GIPR, GLP1R, GCGR APEX1 2901/4885BLM 4161/4885FABP4 1047/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback